Staphylococcal Scalded Skin Syndrome management includes:

• A. Discharge home with oral antibiotics
• B. Observation only
• C. Admit to hospital with IV fluids
• D. Admit to hospital with aggressive IV fluids and IV nafcillin

Answer: (D)

Staphylococcal Scalded Skin Syndrome is caused by exfoliative toxins from Staphylococcus aureus that rapidly damage the superficial epidermis, leading to widespread skin sloughing and huge fluid losses. The management hinges on two priorities: correcting fluid and electrolyte losses and eradicating the toxin-producing bacteria with effective IV antibiotics. Admitting to hospital allows close monitoring and rapid infusion of IV fluids to support perfusion and prevent dehydration and electrolyte imbalance. Using an IV beta-lactamase–resistant penicillin like nafcillin provides reliable coverage against susceptible Staphylococcus aureus, including the MSSA strains commonly responsible for SSSS, helping to halt toxin production and infection progression. Oral antibiotics or leaving the patient for observation alone would risk ongoing fluid loss, potential sepsis, and inadequate control of the source. In severe cases, MRSA concerns can shift therapy to MRSA-active agents, but for typical MSSA-related SSSS, aggressive IV fluids plus IV nafcillin represents the best approach.